Risk stratification of cardiovascular complications using CHA

Atrial Fibrillation / diagnosis Cardiovascular Diseases Heart Diseases Humans Predictive Value of Tests Risk Assessment Risk Factors Stroke
Oral anticoagulation Risk stratification Vascular diseas

Journal

International journal of cardiology
ISSN: 1874-1754
Titre abrégé: Int J Cardiol
Pays: Netherlands
ID NLM: 8200291

Informations de publication

Date de publication:
15 Aug 2021
Historique:
received: 29 12 2020
revised: 26 04 2021
accepted: 29 04 2021
pubmed: 7 5 2021
medline: 15 7 2021
entrez: 6 5 2021
Statut: ppublish

Résumé

Background The COMPASS (Cardiovascular Outcomes for People Using Anticoagulation Strategies) trial showed that rivaroxaban plus aspirin reduced major adverse cardiovascular events (MACE) in patients with chronic coronary artery disease (CAD) and/or peripheral artery disease (PAD). We explored whether CHA

Identifiants

DOI: 10.1016/j.ijcard.2021.04.067 PMID: 33957178
pubmed: 33957178
pii: S0167-5273(21)00810-X
doi: 10.1016/j.ijcard.2021.04.067
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT01776424']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

9-15

Informations de copyright

Copyright © 2021. Published by Elsevier B.V.

Auteurs

Jonathan Sen (J)

Cardiology Research Unit, University Hospital Geelong, Barwon Health, Geelong, Australia; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia. Electronic address: JohnAm@barwonhealth.org.au.

Andrew Tonkin (A)

School of Public Health and Preventive Medicine, Monash University, Australia.

John Varigos (J)

School of Public Health and Preventive Medicine, Monash University, Australia.

Sylvanus Fonguh (S)

Cardiology Research Unit, University Hospital Geelong, Barwon Health, Geelong, Australia.

Scott D Berkowitz (SD)

Research & Development, Pharmaceuticals, Bayer U.S. LLC, Whippany, NJ, United States.

Salim Yusuf (S)

Department of Medicine, Population Health Research Institute, McMaster University, Hamilton Health Sciences, Hamilton, Ontario, Canada.

Peter Verhamme (P)

Department of Cardiovascular Sciences, Center for Molecular and Vascular Biology, University of Leuven, Leuven, Belgium.

Thomas Vanassche (T)

Department of Cardiovascular Sciences, Center for Molecular and Vascular Biology, University of Leuven, Leuven, Belgium.

Sonia S Anand (SS)

Department of Medicine, Population Health Research Institute, McMaster University, Hamilton Health Sciences, Hamilton, Ontario, Canada.

Keith A A Fox (KAA)

Center for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom.

John W Eikelboom (JW)

Department of Medicine, Population Health Research Institute, McMaster University, Hamilton Health Sciences, Hamilton, Ontario, Canada.

John Amerena (J)

Cardiology Research Unit, University Hospital Geelong, Barwon Health, Geelong, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Troubles du rythme cardiaque › Fibrillation auriculaire › Risk stratification of cardiovascular...
questionsmedicales.fr › Maladies cardiovasculaires › Risk stratification of cardiovascular...
questionsmedicales.fr › Maladies cardiovasculaires › Cardiopathies › Risk stratification of cardiovascular...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Risk stratification of cardiovascular...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Méthodologie en recherche épidémiologique › Valeur prédictive des tests › Risk stratification of cardiovascular...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Probabilité › Risque › Appréciation des risques › Risk stratification of cardiovascular...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Probabilité › Risque › Facteurs de risque › Risk stratification of cardiovascular...
questionsmedicales.fr › Maladies cardiovasculaires › Maladies vasculaires › Angiopathies intracrâniennes › Accident vasculaire cérébral › Risk stratification of cardiovascular...